NVO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.42

Margin Of Safety %

-16

Put/Call OI Ratio

0.69

EPS Next Q Diff

3.69

EPS Last/This Y

19.77

EPS This/Next Y

-1.79

Price

45.79

Target Price

48.91

Analyst Recom

2.5

Performance Q

-6.42

Upside

20.9%

Beta

0.8

Ticker: NVO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-15	NVO	40.82	0.69	0.58	1519932
2026-04-20	NVO	40.46	0.71	0.63	1363091
2026-04-23	NVO	38.5	0.71	0.47	1443266
2026-04-24	NVO	41.15	0.71	0.27	1458931
2026-04-27	NVO	41.18	0.68	0.29	1435545
2026-04-28	NVO	41.17	0.67	0.21	1475040
2026-04-29	NVO	40.28	0.67	0.54	1488866
2026-04-30	NVO	42.2	0.68	0.30	1521125
2026-05-01	NVO	43.88	0.68	0.44	1539834
2026-05-04	NVO	44.4	0.69	0.29	1515880
2026-05-05	NVO	44.9	0.69	0.50	1537073
2026-05-06	NVO	45.74	0.68	0.39	1584436
2026-05-07	NVO	45.81	0.68	0.42	1592900
2026-05-08	NVO	46.09	0.68	0.28	1603572
2026-05-11	NVO	46.4	0.69	0.38	1501570
2026-05-12	NVO	46.97	0.69	0.34	1510947
2026-05-13	NVO	47.08	0.69	0.52	1519844
2026-05-14	NVO	45.81	0.69	0.28	1531138
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-15	NVO	40.81	4.6	-803.4	21.44
2026-04-16	NVO	40.92	4.6	-1169.2	21.44
2026-04-17	NVO	40.50	6.6	-1725.0	21.44
2026-04-20	NVO	40.47	6.6	-1955.0	21.44
2026-04-21	NVO	39.42	6.6	-2083.0	21.87
2026-04-22	NVO	39.15	6.6	-1281.1	21.87
2026-04-23	NVO	38.51	6.6	-1706.9	21.98
2026-04-24	NVO	41.17	6.6	-327.7	21.98
2026-04-27	NVO	41.19	6.6	-1280.7	21.98
2026-04-28	NVO	41.16	6.6	-1799.2	21.98
2026-04-30	NVO	42.20	6.6	-816.1	21.98
2026-05-01	NVO	43.88	6.6	-1257.0	21.98
2026-05-04	NVO	44.40	6.6	-1418.3	21.98
2026-05-05	NVO	44.90	6.6	-1533.3	21.98
2026-05-06	NVO	45.75	6.6	-1402.4	21.98
2026-05-07	NVO	45.78	6.6	-14501.7	21.98
2026-05-08	NVO	46.08	6.6	-14310.4	21.98
2026-05-11	NVO	46.40	-12.9	-13530.0	26.55
2026-05-12	NVO	46.98	-12.9	-13986.1	23.37
2026-05-13	NVO	47.08	-12.9	-13848.8	23.37
2026-05-14	NVO	45.79	-12.9	-14208.4	23.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-15	NVO	0.00	0.16	0.59
2026-04-16	NVO	0.00	0.16	0.59
2026-04-17	NVO	0.00	0.16	0.59
2026-04-20	NVO	0.00	0.06	0.59
2026-04-21	NVO	0.00	0.06	0.59
2026-04-22	NVO	0.00	0.06	0.59
2026-04-23	NVO	0.00	0.06	0.59
2026-04-24	NVO	0	0.06	0.59
2026-04-27	NVO	0	-0.15	0.51
2026-04-28	NVO	0	-0.15	0.51
2026-04-29	NVO	0	-0.15	0.51
2026-04-30	NVO	0	-0.15	0.51
2026-05-01	NVO	0	-0.15	0.51
2026-05-04	NVO	0	-0.36	0.51
2026-05-05	NVO	0	-0.36	0.51
2026-05-06	NVO	0	-0.36	0.51
2026-05-07	NVO	0	-0.36	0.51
2026-05-08	NVO	0	-0.36	0.51
2026-05-11	NVO	0	-0.56	0
2026-05-12	NVO	0	-0.56	0.42
2026-05-13	NVO	0	-0.56	0.42
2026-05-14	NVO	0	-0.56	0.42
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.04

Avg. EPS Est. Current Quarter

5.19

Avg. EPS Est. Next Quarter

4.73

Insider Transactions

Institutional Transactions

-0.56

Beta

0.8

Average Sales Estimate Current Quarter

72241

Average Sales Estimate Next Quarter

71299

Fair Value

38.65

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

69.1

Max Drawdown 5-Year %

-74.7

Target Price

48.91

P/E

10.75

Forward P/E

13.73

PEG

52.79

P/S

3.03

P/B

6.5

P/Free Cash Flow

24.05

EPS

4.26

Average EPS Est. Cur. Y

23.37

EPS Next Y. (Est.)

21.58

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

37.23

Relative Volume

0.62

Return on Equity vs Sector %

33.2

Return on Equity vs Industry %

EPS 1 7Days Diff

1.4

EPS 1 30Days Diff

1.91

EBIT Estimation

-14208.4

◆ NVO Healthcare

$45.79

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

6/20

Pullback

0/25

Volume

9/15

Valuation

11/20

TP/AR

1/10

Options

7/10

RSI

66.4

Range 1M

79.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

13/30

Estimates

6/20

Inst/Vol

0/15

Options

6/10

EPS Yr

-8.6%

EPS NY

0.3%

52W%

23.1%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +253% upside

Quality

30/30

Valuation

19/30

Growth

11/25

Stability

3/10

LT Trend

4/5

Upside

+253%

Quality

MoS

-16%

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 67900

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; and growth hormone pens and injection needles. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NVO

Latest News

—

Caricamento notizie per NVO…

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y